Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationTransplantation, HomologousHematopoietic Stem Cell MobilizationTransplantation ConditioningBone Marrow TransplantationMelphalanGranulocyte Colony-Stimulating FactorHematologic NeoplasmsCombined Modality TherapyLeukapheresisAntigens, CD34Stem Cell TransplantationGraft vs Host DiseaseBlood Component RemovalCyclophosphamideMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsBusulfanHematopoietic Stem CellsStem CellsMyeloablative AgonistsGraft SurvivalTreatment OutcomeLymphoma, Non-HodgkinBlood Transfusion, AutologousEtoposideRecurrenceRemission InductionThiotepaAntineoplastic Agents, AlkylatingCarmustineCytophagocytosisTransplantation ChimeraSalvage TherapyHematopoiesisIfosfamideTissue DonorsVincristineAmyloidosisCord Blood Stem Cell TransplantationRetrospective StudiesCytarabineHodgkin DiseaseWhole-Body IrradiationDisease-Free SurvivalSurvival RateBone MarrowHistocompatibility TestingNeoplasmsTime FactorsImmunosuppressive AgentsHistocompatibilitySurvival AnalysisLeukemiaInfectionLymphoma, T-CellLeukemia, Myeloid, AcuteTransplantation, IsogeneicPlatelet CountDoxorubicinBone Marrow CellsCytomegalovirus InfectionsVidarabinePOEMS SyndromeBlood TransfusionPrednisoneFollow-Up StudiesBone Marrow PurgingCarboplatinProspective StudiesAnemia, AplasticBlood Cell CountRecombinant ProteinsDexamethasoneGraft vs Leukemia EffectFatal OutcomeBlood CellsLymphomaAntineoplastic AgentsMyelodysplastic SyndromesEmbryonic Stem CellsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveFeasibility StudiesLymphocyte DepletionT-LymphocytesImmunophenotypingOperative Blood SalvageImmunosuppressionAdult Stem CellsBlood DonorsCyclosporineOpportunistic InfectionsMesenchymal Stem Cell TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaHLA AntigensHematologic DiseasesKidney TransplantationCell Separation